4579 — RaQualia Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for RaQualia Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	—	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,659	3,926	3,765	3,342	3,244
Net Total Accounts Receivable
Net Total Receivables	1,205	602	603	689	1,928
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,004	4,822	4,957	4,539	5,682
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	299	391	574	529	436
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5,234	6,258	6,872	9,655	10,514
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	401	494	389	1,187	1,275
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	446	761	752	4,085	3,618
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	4,788	5,497	6,120	5,571	6,896
Total Liabilities & Shareholders' Equity	5,234	6,258	6,872	9,655	10,514
Total Common Shares Outstanding